Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
13F holders, Q3 2025 (September 30)4holders −1
0new positions
1sold out
$0.98avg. 13F price*
At the end of Q3 2025, 4 institutions reported holding Bridgebio Pharma Inc. (bbio 2.25 02/01/29) in their 13F filings, down 1 from Q2 2025. 0 opened new positions and 1 sold out. The largest holders were New York State Common Retirement Fund ($2.8M), BNP PARIBAS ASSET MANAGEMENT Holding S.A. ($2.5M) and Sei Investments Co. ($267K).
- Company
- Bridgebio Pharma Inc. (bbio 2.25 02/01/29)
- CUSIP
- 10806XAD4
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 1 | $3.7M |
All 13F filers, Q2 2025 → Q3 2025: 4,211,000 shares sold, net −4,211,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 4 holders
| New York State Common Retirement Fund | 0.00% | Reduce -6.5% | 2,859,000 | $2.8M |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 0.01% | No change | 2,500,000 | $2.5M |
| Sei Investments Co. | 0.00% | No change | 271,000 | $267K |
| Bank of New York Mellon Corp | 0.00% | No change | 200,000 | $198K |
"% of holder's portfolio" is BRIDGEBIO PHARMA INC (BBIO 2.25 02/01/29)'s weight in each manager's 13F, not the share of Bridgebio Pharma Inc. (bbio 2.25 02/01/29) the manager owns.